A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
Influenza A viruses (IAVs) pose a global health threat, contributing to hundreds of thousands of deaths and millions of hospitalizations annually. The two major surface glycoproteins of IAVs, hemagglutinin (HA) and neuraminidase (NA), are important antigens in eliciting neutralizing antibodies and p...
Main Authors: | Vasilis C. Pliasas, Zach Menne, Virginia Aida, Ji-Hang Yin, Maria C. Naskou, Peter J. Neasham, J. Fletcher North, Dylan Wilson, Katharine A. Horzmann, Joshy Jacob, Ioanna Skountzou, Constantinos S. Kyriakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.915364/full |
Similar Items
-
Development and characterization of an immortalized swine respiratory cell line for influenza A virus research
by: Peter J. Neasham, et al.
Published: (2023-12-01) -
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model
by: Vasilis C. Pliasas, et al.
Published: (2023-10-01) -
Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
by: Virginia Aida, et al.
Published: (2021-04-01) -
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
by: Florian Krammer, et al.
Published: (2018-05-01) -
Editorial: Novel Vaccine Technologies in Animal Health
by: Vasilis C. Pliasas, et al.
Published: (2022-02-01)